#Business #WallStreet
L’Oreal agreed to buy the 10% stake, valued at roughly $1.9 billion, to bolster its exposure to the fast-growing market for aesthetic injections such as fillers.
WSJ.com: US Business
PAID
This is a business article located in the U.S. Business section of the Wall Street Journal. For the latest articles on U.S. business, current markets and other business related news follow our Twitter Page or bookmark this website.
